Aids in determining past or present Epstein-Barr virus (EBV) infection as well as susceptibility to future EBV infection. May be used in conjunction with EBV nuclear antigen to diagnose primary EBV infectious mononucleosis.
Semi-Quantitative Chemiluminescent Immunoassay
New York DOH Approval Status
Serum Separator Tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Contaminated, heat-inactivated, or grossly hemolyzed specimens.
Label specimens plainly as "acute" or "convalescent."
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (Avoid repeated freeze/thaw cycles).
|0050235||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG||Effective February 19, 2013
17.9 U/mL or less: Not Detected
18.0-21.9 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
22.0 U/mL or greater: Detected
|0050240||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgM||Effective February 19, 2013
35.9 U/mL or less: Not Detected
36.0-43.9 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
44.0 U/mL or greater: Detected
|Component Test Code*||Component Chart Name||LOINC|
|0050235||EBV Antibody to Viral Capsid Antigen IgG||7885-7|
|0050240||EBV Antibody to Viral Capsid Antigen IgM||7886-5|
- EBV Antibodies
- EBV Antibody Panel II
- EBV VCA-IgG Ab
- EBV VCA-IgM Ab
- Infectious Mononucleosis Antibody Panel
- VCA (Viral Capsid Antigen) IgG and IgM